183 related articles for article (PubMed ID: 16406700)
1. Holding T cells in check--a new role for complement regulators?
Longhi MP; Harris CL; Morgan BP; Gallimore A
Trends Immunol; 2006 Feb; 27(2):102-8. PubMed ID: 16406700
[TBL] [Abstract][Full Text] [Related]
2. Rat T cells express neither CD55 nor CD59 and are dependent on Crry for protection from homologous complement.
Hanna S; Spiller O; Linton SM; Mead RJ; Morgan B
Eur J Immunol; 2002 Feb; 32(2):502-9. PubMed ID: 11828367
[TBL] [Abstract][Full Text] [Related]
3. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
[TBL] [Abstract][Full Text] [Related]
4. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
5. DAF/CD55 and Protectin/CD59 modulate adaptive immunity and disease outcome in experimental autoimmune myasthenia gravis.
Soltys J; Halperin JA; Xuebin Q
J Neuroimmunol; 2012 Mar; 244(1-2):63-9. PubMed ID: 22325826
[TBL] [Abstract][Full Text] [Related]
6. Complement regulatory proteins in early human fetal life: CD59, membrane co-factor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver.
Simpson KL; Houlihan JM; Holmes CH
Immunology; 1993 Oct; 80(2):183-90. PubMed ID: 7505254
[TBL] [Abstract][Full Text] [Related]
7. Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization.
Li Y; Parks GD
Viruses; 2018 Apr; 10(5):. PubMed ID: 29693588
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
[TBL] [Abstract][Full Text] [Related]
9. Cell surface regulators of complement, 5I2 antigen, and CD59, in the rat eye and adnexal tissues.
Bardenstein DS; Cheyer C; Okada N; Morgan BP; Medof ME
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):519-24. PubMed ID: 9950613
[TBL] [Abstract][Full Text] [Related]
10. Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation.
Varsano S; Frolkis I; Rashkovsky L; Ophir D; Fishelson Z
Am J Respir Cell Mol Biol; 1996 Dec; 15(6):731-7. PubMed ID: 8969267
[TBL] [Abstract][Full Text] [Related]
11. The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues.
Thorsteinsson L; O'Dowd GM; Harrington PM; Johnson PM
APMIS; 1998 Sep; 106(9):869-78. PubMed ID: 9808413
[TBL] [Abstract][Full Text] [Related]
12. Complement modulation of T cell immune responses during homeostasis and disease.
Clarke EV; Tenner AJ
J Leukoc Biol; 2014 Nov; 96(5):745-56. PubMed ID: 25210145
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
[TBL] [Abstract][Full Text] [Related]
14. Complement as a regulator of adaptive immunity.
Killick J; Morisse G; Sieger D; Astier AL
Semin Immunopathol; 2018 Jan; 40(1):37-48. PubMed ID: 28842749
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M
Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.
Spiller OB; Criado-García O; Rodríguez De Córdoba S; Morgan BP
Clin Exp Immunol; 2000 Aug; 121(2):234-41. PubMed ID: 10931136
[TBL] [Abstract][Full Text] [Related]
17. CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59.
Golay J; Lazzari M; Facchinetti V; Bernasconi S; Borleri G; Barbui T; Rambaldi A; Introna M
Blood; 2001 Dec; 98(12):3383-9. PubMed ID: 11719378
[TBL] [Abstract][Full Text] [Related]
18. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
[TBL] [Abstract][Full Text] [Related]
19. Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells.
Bao L; Haas M; Pippin J; Wang Y; Miwa T; Chang A; Minto AW; Petkova M; Qiao G; Song WC; Alpers CE; Zhang J; Shankland SJ; Quigg RJ
J Clin Invest; 2009 May; 119(5):1264-74. PubMed ID: 19349693
[TBL] [Abstract][Full Text] [Related]
20. Mouse CD4+ CD25+ T regulatory cells are protected from autologous complement mediated injury by Crry and CD59.
Li Q; Nacion K; Bu H; Lin F
Biochem Biophys Res Commun; 2009 Apr; 382(1):223-6. PubMed ID: 19281793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
